Holen Sie sich die Stockscreener-App
139.92
0.50%
-0.71
Handel nachbörslich:
139.92
Schlusskurs vom Vortag:
$140.63
Offen:
$140.95
24-Stunden-Volumen:
1.13M
Relative Volume:
0.91
Marktkapitalisierung:
$19.11B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$-214.69M
KGV:
-79.50
EPS:
-1.76
Netto-Cashflow:
$-43.68M
1W Leistung:
-6.63%
1M Leistung:
-18.58%
6M Leistung:
-18.62%
1J Leistung:
+32.61%
1-Tages-Spanne:
$138.82
$142.38
1-Wochen-Bereich:
$138.50
$151.09
52-Wochen-Spanne:
$92.14
$183.00
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
139.92 | 20.46B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera CFO Brophy sold $83,852 in NTRA stock - Investing.com Australia
Natera CEO Chapman sells $225,928 in shares - Investing.com
Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia
Natera president Fesko sells $273k in stock - Investing.com Australia
Natera Inc: President Moshkevich sells $299k in shares - Investing.com
Natera’s chief legal officer sells $3.4 million in stock - Investing.com
Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
What analysts say about Natera Inc. stockFree Investment Community - jammulinksnews.com
What drives Natera Inc. stock priceExceptional portfolio growth - jammulinksnews.com
Natera Inc. Stock Analysis and ForecastJaw-dropping returns - Autocar Professional
Natera director Sheena Jonathan sells $460k in stock By Investing.com - Investing.com Nigeria
Natera director Sheena Jonathan sells $460k in stock - Investing.com
Natera(NTRA) Shares Plunge 3.12% Amid Market, Regulatory Challenges - AInvest
When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com
Natera(NTRA) Shares Plunge 9.16% Amid Regulatory Hurdles - AInvest
What makes Natera Inc. stock price move sharplySafety First Trading Signals - beatles.ru
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera's $234M Trading Volume Ranks 433rd Amid Market Challenges - AInvest
Special master to decide whether Quinn Emanuel lawyers must contribute to $3M sanction - ABA Journal
Natera, Inc. (NTRA): A Bull Case Theory - Insider Monkey
Is Natera (NASDAQ:NTRA) Using Too Much Debt? - 富途牛牛
Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360
US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters
Mike Brophy is regarded as one of Austin's best CFOs - The Business Journals
Natera's 'Signatera' detects recurrence of cancer through a blood test - Fox Business
Natera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Natera Rings the Opening Bell - Nasdaq
Natera presents data from Latitude MRD assay study at ESMO Congress - TipRanks
Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer - New Castle News
User - FinancialContent
Should You Invest in Natera (NTRA)? - Insider Monkey
Bankruptcy Judge Lets Del. Court Take Invitae Contract Fight - Law360
Natera Inks $8.25M Deal To End Prenatal Tests Suit - Law360
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD - Yahoo Finance
Natera, Inc.(NasdaqGS: NTRA) dropped from Russell 2500 Growth Index - MarketScreener
Q1 Immuno-Oncology Earnings Review: First Prize Goes to Natera (NASDAQ:NTRA) - Yahoo Finance
Shares of Natera (NTRA) Fall as Executive Chairman Sells Company Stock - TipRanks
Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target - Insider Monkey
If You Can Only Buy 1 Cathie Wood Stock In 2025, It Should Be This - Barchart.com
Natera Inc: Executive chairman Rabinowitz sells $8.38 million in NTRA stock - Investing.com UK
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):